Wakamoto Pharmaceutical Co.,Ltd. (4512.T)
JPY 282.0
(-2.76%)
JPY 282.0
(-2.76%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -195.51 Million JPY | -238.2% |
| 2022 | 141.46 Million JPY | 1156.83% |
| 2021 | -13.38 Million JPY | 98.23% |
| 2020 | -754.94 Million JPY | 24.22% |
| 2019 | -996.27 Million JPY | -154.79% |
| 2018 | -391.01 Million JPY | -432.05% |
| 2017 | -73.49 Million JPY | -184.15% |
| 2016 | 87.33 Million JPY | 4.94% |
| 2015 | 83.22 Million JPY | -19.04% |
| 2014 | 102.79 Million JPY | -18.36% |
| 2013 | 125.92 Million JPY | 493.74% |
| 2012 | 21.2 Million JPY | 104.25% |
| 2011 | -499.12 Million JPY | 33.92% |
| 2010 | -755.37 Million JPY | -1621.23% |
| 2009 | -43.88 Million JPY | -121.56% |
| 2008 | 203.51 Million JPY | -66.54% |
| 2007 | 608.25 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -89.37 Million JPY | -182.64% |
| 2023 Q1 | -57.89 Million JPY | -153.53% |
| 2023 FY | -195.51 Million JPY | -238.2% |
| 2023 Q4 | 108.15 Million JPY | 57.52% |
| 2023 Q3 | 68.65 Million JPY | 125.38% |
| 2023 Q2 | -270.48 Million JPY | -367.2% |
| 2022 Q3 | 119.26 Million JPY | 294.3% |
| 2022 FY | 141.46 Million JPY | 1156.83% |
| 2022 Q4 | 108.15 Million JPY | -9.32% |
| 2022 Q2 | -61.38 Million JPY | -149.88% |
| 2022 Q1 | -24.56 Million JPY | -129.82% |
| 2021 Q3 | 76.4 Million JPY | 161.08% |
| 2021 FY | -13.38 Million JPY | 98.23% |
| 2021 Q4 | 82.38 Million JPY | 7.83% |
| 2021 Q1 | -47.09 Million JPY | 70.65% |
| 2021 Q2 | -125.08 Million JPY | -165.61% |
| 2020 Q3 | 22.59 Million JPY | 105.6% |
| 2020 Q2 | -403.84 Million JPY | -89.37% |
| 2020 Q1 | -213.25 Million JPY | -55.43% |
| 2020 Q4 | -160.44 Million JPY | -810.05% |
| 2020 FY | -754.94 Million JPY | 24.22% |
| 2019 Q1 | -251.52 Million JPY | 45.1% |
| 2019 FY | -996.27 Million JPY | -154.79% |
| 2019 Q2 | -648.97 Million JPY | -158.01% |
| 2019 Q3 | 41.42 Million JPY | 106.38% |
| 2019 Q4 | -137.2 Million JPY | -431.21% |
| 2018 Q4 | -458.18 Million JPY | -509.47% |
| 2018 FY | -391.01 Million JPY | -432.05% |
| 2018 Q1 | 137.58 Million JPY | 270.76% |
| 2018 Q3 | 111.89 Million JPY | 161.38% |
| 2018 Q2 | -182.3 Million JPY | -232.51% |
| 2017 Q4 | -80.56 Million JPY | -171.53% |
| 2017 Q2 | -240.43 Million JPY | -278.27% |
| 2017 FY | -73.49 Million JPY | -184.15% |
| 2017 Q1 | 134.87 Million JPY | 722.06% |
| 2017 Q3 | 112.63 Million JPY | 146.85% |
| 2016 FY | 87.33 Million JPY | 4.94% |
| 2016 Q1 | 125.71 Million JPY | 190.81% |
| 2016 Q3 | 130.62 Million JPY | 170.45% |
| 2016 Q2 | -185.4 Million JPY | -247.48% |
| 2016 Q4 | 16.4 Million JPY | -87.44% |
| 2015 Q3 | 203.15 Million JPY | 362.66% |
| 2015 Q4 | -138.43 Million JPY | -168.14% |
| 2015 FY | 83.22 Million JPY | -19.04% |
| 2015 Q1 | 95.84 Million JPY | 170.23% |
| 2015 Q2 | -77.34 Million JPY | -180.69% |
| 2014 Q4 | -136.47 Million JPY | -147.07% |
| 2014 FY | 102.79 Million JPY | -18.36% |
| 2014 Q3 | 289.94 Million JPY | 995.55% |
| 2014 Q2 | -32.37 Million JPY | -77.02% |
| 2014 Q1 | -18.28 Million JPY | 65.38% |
| 2013 Q3 | 301.51 Million JPY | 362.52% |
| 2013 Q4 | -52.82 Million JPY | -117.52% |
| 2013 FY | 125.92 Million JPY | 493.74% |
| 2013 Q1 | -7.91 Million JPY | -104.03% |
| 2013 Q2 | -114.85 Million JPY | -1351.28% |
| 2012 Q3 | 147.55 Million JPY | 153.08% |
| 2012 Q4 | 196.36 Million JPY | 33.08% |
| 2012 FY | 21.2 Million JPY | 104.25% |
| 2012 Q1 | -44.75 Million JPY | 65.62% |
| 2012 Q2 | -277.96 Million JPY | -521.11% |
| 2011 FY | -499.12 Million JPY | 33.92% |
| 2011 Q1 | -202.72 Million JPY | -592.67% |
| 2011 Q2 | -146.79 Million JPY | 27.59% |
| 2011 Q3 | -19.43 Million JPY | 86.76% |
| 2011 Q4 | -130.17 Million JPY | -569.8% |
| 2010 FY | -755.37 Million JPY | -1621.23% |
| 2010 Q2 | -426.31 Million JPY | -105.4% |
| 2010 Q1 | -207.55 Million JPY | -51.17% |
| 2010 Q3 | -92.24 Million JPY | 78.36% |
| 2010 Q4 | -29.26 Million JPY | 68.27% |
| 2009 Q4 | -137.3 Million JPY | -212.96% |
| 2009 Q1 | -169.35 Million JPY | 0.97% |
| 2009 FY | -43.88 Million JPY | -121.56% |
| 2009 Q2 | 139.22 Million JPY | 182.21% |
| 2009 Q3 | 121.54 Million JPY | -12.7% |
| 2008 Q4 | -171.01 Million JPY | -229.19% |
| 2008 Q3 | 132.37 Million JPY | 241.79% |
| 2008 Q2 | 38.73 Million JPY | 0.0% |
| 2008 FY | 203.51 Million JPY | -66.54% |
| 2007 FY | 608.25 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 5.11 Billion JPY | 103.824% |
| Takeda Pharmaceutical Company Limited | 214.07 Billion JPY | 100.091% |
| Sumitomo Pharma Co., Ltd. | -354.19 Billion JPY | 99.945% |
| Shionogi & Co., Ltd. | 171.46 Billion JPY | 100.114% |
| Nippon Shinyaku Co., Ltd. | 31.38 Billion JPY | 100.623% |
| Kaken Pharmaceutical Co., Ltd. | 9.51 Billion JPY | 102.055% |
| Eisai Co., Ltd. | 53.4 Billion JPY | 100.366% |
| Morishita Jintan Co., Ltd. | 716 Million JPY | 127.306% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.16 Billion JPY | 101.485% |
| Mochida Pharmaceutical Co., Ltd. | 5.8 Billion JPY | 103.369% |
| Fuso Pharmaceutical Industries,Ltd. | 1.96 Billion JPY | 109.955% |
| Nippon Chemiphar Co., Ltd. | -494 Million JPY | 60.423% |
| Tsumura & Co. | 20.01 Billion JPY | 100.977% |
| Kissei Pharmaceutical Co., Ltd. | 4.01 Billion JPY | 104.867% |
| Torii Pharmaceutical Co., Ltd. | 5.03 Billion JPY | 103.882% |
| Towa Pharmaceutical Co., Ltd. | 17.64 Billion JPY | 101.108% |
| Fuji Pharma Co., Ltd. | 3.85 Billion JPY | 105.068% |
| Zeria Pharmaceutical Co., Ltd. | 9.71 Billion JPY | 102.012% |
| KYORIN Holdings, Inc. | 6.01 Billion JPY | 103.251% |
| Taiko Pharmaceutical Co.,Ltd. | -3.07 Billion JPY | 93.65% |
| Daito Pharmaceutical Co.,Ltd. | 3.89 Billion JPY | 105.021% |
| SymBio Pharmaceuticals Limited | -811.66 Million JPY | 75.912% |
| MedRx Co., Ltd | -933 Million JPY | 79.045% |
| Mizuho Medy Co.,Ltd. | 5.15 Billion JPY | 103.795% |
| Solasia Pharma K.K. | -1.13 Billion JPY | 82.835% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 91.751% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 6.5 Billion JPY | 103.008% |
| Sawai Group Holdings Co., Ltd. | 18.88 Billion JPY | 101.035% |
| Cyfuse Biomedical K.K. | -697.43 Million JPY | 71.967% |
| Toho Holdings Co., Ltd. | 19.33 Billion JPY | 101.011% |
| Koa Shoji Holdings Co.,Ltd. | 4.38 Billion JPY | 104.461% |